{"name":"Horng Chen","slug":"horng-chen","ticker":"","exchange":"","domain":"","description":"Horng Chen is a biotechnology company focused on the development of novel cardiovascular diagnostics and therapies. The company is currently advancing its lead candidate, B-type Natriuretic Peptide (BNP), through Phase 1 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOSWVRb3NTWkZTVm1WQm9fT2pBZFY0N0tIMzVXVlFTN0dTWVd1NDdka01UOE56bTdMWDVOSjVON2tDaGxrVlAwYnBXRmRHbVI3S1dicEludGxiYThqVHByYTJQX3RpY0h2OUVKZFNSZkNuYzJWTWRLR0ZxZE9Xb1hjU2JvRlJ4Zm1iYlBYRncwV2Y4eGFqblB1LVNNMjhyZ1RzM0l2VTRFcExVX2VtVXFwQmNTNk0?oc=5","date":"2023-08-28","type":"pipeline","source":"Forbes","summary":"Meet Taiwan’s Little-Known But Elite Semiconductor Makers - Forbes","headline":"Meet Taiwan’s Little-Known But Elite Semiconductor Makers","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}